nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA6—ear—melanoma	0.0284	0.287	CbGeAlD
Brinzolamide—CYP3A4—Temozolomide—melanoma	0.019	0.576	CbGbCtD
Brinzolamide—CA6—hair follicle—melanoma	0.015	0.151	CbGeAlD
Brinzolamide—CYP3A4—Vemurafenib—melanoma	0.0104	0.316	CbGbCtD
Brinzolamide—CA2—hair follicle—melanoma	0.00515	0.0521	CbGeAlD
Brinzolamide—CA12—eye—melanoma	0.00501	0.0507	CbGeAlD
Brinzolamide—CA6—head—melanoma	0.00424	0.0429	CbGeAlD
Brinzolamide—CA4—neck—melanoma	0.00417	0.0422	CbGeAlD
Brinzolamide—CA1—eye—melanoma	0.00397	0.0402	CbGeAlD
Brinzolamide—Eye irritation—Docetaxel—melanoma	0.0037	0.00559	CcSEcCtD
Brinzolamide—Amnesia—Temozolomide—melanoma	0.00367	0.00555	CcSEcCtD
Brinzolamide—CYP3A4—Docetaxel—melanoma	0.00358	0.108	CbGbCtD
Brinzolamide—Chest discomfort—Docetaxel—melanoma	0.00357	0.0054	CcSEcCtD
Brinzolamide—Diplopia—Carmustine—melanoma	0.00356	0.00539	CcSEcCtD
Brinzolamide—CA5B—mammalian vulva—melanoma	0.00356	0.0361	CbGeAlD
Brinzolamide—Cough—Vemurafenib—melanoma	0.00354	0.00536	CcSEcCtD
Brinzolamide—Liver function test abnormal—Dactinomycin—melanoma	0.00352	0.00532	CcSEcCtD
Brinzolamide—Oropharyngeal pain—Docetaxel—melanoma	0.00347	0.00525	CcSEcCtD
Brinzolamide—CA2—neck—melanoma	0.00346	0.035	CbGeAlD
Brinzolamide—Arthralgia—Vemurafenib—melanoma	0.00346	0.00523	CcSEcCtD
Brinzolamide—Myalgia—Vemurafenib—melanoma	0.00346	0.00523	CcSEcCtD
Brinzolamide—Diplopia—Temozolomide—melanoma	0.00345	0.00521	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00343	0.00519	CcSEcCtD
Brinzolamide—Lacrimation increased—Docetaxel—melanoma	0.00342	0.00518	CcSEcCtD
Brinzolamide—Infection—Vemurafenib—melanoma	0.00329	0.00498	CcSEcCtD
Brinzolamide—Liver function test abnormal—Carmustine—melanoma	0.00329	0.00498	CcSEcCtD
Brinzolamide—Nervous system disorder—Vemurafenib—melanoma	0.00325	0.00492	CcSEcCtD
Brinzolamide—Skin disorder—Vemurafenib—melanoma	0.00322	0.00487	CcSEcCtD
Brinzolamide—Blood pressure increased—Docetaxel—melanoma	0.00316	0.00478	CcSEcCtD
Brinzolamide—Breast disorder—Temozolomide—melanoma	0.00311	0.00471	CcSEcCtD
Brinzolamide—Hypotension—Vemurafenib—melanoma	0.0031	0.00468	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00302	0.00457	CcSEcCtD
Brinzolamide—Oesophagitis—Docetaxel—melanoma	0.00288	0.00436	CcSEcCtD
Brinzolamide—Decreased appetite—Vemurafenib—melanoma	0.00288	0.00436	CcSEcCtD
Brinzolamide—Bronchitis—Temozolomide—melanoma	0.00286	0.00433	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00286	0.00433	CcSEcCtD
Brinzolamide—Fatigue—Vemurafenib—melanoma	0.00286	0.00432	CcSEcCtD
Brinzolamide—CA12—head—melanoma	0.00284	0.0288	CbGeAlD
Brinzolamide—Hypoaesthesia—Bleomycin—melanoma	0.00281	0.00425	CcSEcCtD
Brinzolamide—Pollakiuria—Temozolomide—melanoma	0.00275	0.00416	CcSEcCtD
Brinzolamide—Erectile dysfunction—Temozolomide—melanoma	0.00274	0.00415	CcSEcCtD
Brinzolamide—Depression—Carmustine—melanoma	0.00274	0.00415	CcSEcCtD
Brinzolamide—Infestation NOS—Temozolomide—melanoma	0.00265	0.00402	CcSEcCtD
Brinzolamide—Infestation—Temozolomide—melanoma	0.00265	0.00402	CcSEcCtD
Brinzolamide—Depression—Temozolomide—melanoma	0.00265	0.00401	CcSEcCtD
Brinzolamide—Pharyngitis—Dactinomycin—melanoma	0.00262	0.00396	CcSEcCtD
Brinzolamide—CA2—eye—melanoma	0.00257	0.026	CbGeAlD
Brinzolamide—CA5B—head—melanoma	0.00255	0.0258	CbGeAlD
Brinzolamide—CA2—retina—melanoma	0.00255	0.0258	CbGeAlD
Brinzolamide—Hepatobiliary disease—Temozolomide—melanoma	0.00251	0.0038	CcSEcCtD
Brinzolamide—Alopecia—Bleomycin—melanoma	0.0025	0.00378	CcSEcCtD
Brinzolamide—Sinusitis—Temozolomide—melanoma	0.00249	0.00377	CcSEcCtD
Brinzolamide—Erythema—Bleomycin—melanoma	0.00246	0.00372	CcSEcCtD
Brinzolamide—Hypoaesthesia—Carmustine—melanoma	0.00245	0.00371	CcSEcCtD
Brinzolamide—Hypersensitivity—Vemurafenib—melanoma	0.00244	0.00369	CcSEcCtD
Brinzolamide—Oedema peripheral—Carmustine—melanoma	0.00243	0.00368	CcSEcCtD
Brinzolamide—Connective tissue disorder—Carmustine—melanoma	0.00242	0.00367	CcSEcCtD
Brinzolamide—Visual disturbance—Docetaxel—melanoma	0.00242	0.00366	CcSEcCtD
Brinzolamide—Asthenia—Vemurafenib—melanoma	0.00238	0.0036	CcSEcCtD
Brinzolamide—Visual impairment—Carmustine—melanoma	0.00238	0.0036	CcSEcCtD
Brinzolamide—Hypoaesthesia—Temozolomide—melanoma	0.00237	0.00359	CcSEcCtD
Brinzolamide—Pharyngitis—Temozolomide—melanoma	0.00237	0.00358	CcSEcCtD
Brinzolamide—Urinary tract disorder—Temozolomide—melanoma	0.00235	0.00356	CcSEcCtD
Brinzolamide—Oedema peripheral—Temozolomide—melanoma	0.00235	0.00355	CcSEcCtD
Brinzolamide—Pruritus—Vemurafenib—melanoma	0.00234	0.00355	CcSEcCtD
Brinzolamide—Connective tissue disorder—Temozolomide—melanoma	0.00234	0.00354	CcSEcCtD
Brinzolamide—Urethral disorder—Temozolomide—melanoma	0.00234	0.00354	CcSEcCtD
Brinzolamide—Alopecia—Dactinomycin—melanoma	0.00233	0.00352	CcSEcCtD
Brinzolamide—Eye disorder—Carmustine—melanoma	0.0023	0.00349	CcSEcCtD
Brinzolamide—Visual impairment—Temozolomide—melanoma	0.0023	0.00348	CcSEcCtD
Brinzolamide—Erythema—Dactinomycin—melanoma	0.00229	0.00347	CcSEcCtD
Brinzolamide—Pain in extremity—Docetaxel—melanoma	0.00229	0.00347	CcSEcCtD
Brinzolamide—Ill-defined disorder—Bleomycin—melanoma	0.00228	0.00345	CcSEcCtD
Brinzolamide—Diarrhoea—Vemurafenib—melanoma	0.00227	0.00343	CcSEcCtD
Brinzolamide—CA1—head—melanoma	0.00225	0.0228	CbGeAlD
Brinzolamide—CA2—skin of body—melanoma	0.00224	0.0226	CbGeAlD
Brinzolamide—Eye disorder—Temozolomide—melanoma	0.00223	0.00337	CcSEcCtD
Brinzolamide—Tinnitus—Temozolomide—melanoma	0.00222	0.00336	CcSEcCtD
Brinzolamide—Malaise—Bleomycin—melanoma	0.00222	0.00336	CcSEcCtD
Brinzolamide—Cardiac disorder—Temozolomide—melanoma	0.00221	0.00335	CcSEcCtD
Brinzolamide—Arrhythmia—Carmustine—melanoma	0.0022	0.00333	CcSEcCtD
Brinzolamide—Dizziness—Vemurafenib—melanoma	0.00219	0.00332	CcSEcCtD
Brinzolamide—Alopecia—Carmustine—melanoma	0.00218	0.0033	CcSEcCtD
Brinzolamide—Angiopathy—Temozolomide—melanoma	0.00216	0.00327	CcSEcCtD
Brinzolamide—Mental disorder—Carmustine—melanoma	0.00216	0.00327	CcSEcCtD
Brinzolamide—Immune system disorder—Temozolomide—melanoma	0.00215	0.00326	CcSEcCtD
Brinzolamide—Mediastinal disorder—Temozolomide—melanoma	0.00215	0.00325	CcSEcCtD
Brinzolamide—Erythema—Carmustine—melanoma	0.00215	0.00325	CcSEcCtD
Brinzolamide—Malnutrition—Carmustine—melanoma	0.00215	0.00325	CcSEcCtD
Brinzolamide—Cough—Bleomycin—melanoma	0.00215	0.00325	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dactinomycin—melanoma	0.00213	0.00322	CcSEcCtD
Brinzolamide—Liver function test abnormal—Docetaxel—melanoma	0.00212	0.0032	CcSEcCtD
Brinzolamide—Vomiting—Vemurafenib—melanoma	0.00211	0.00319	CcSEcCtD
Brinzolamide—Alopecia—Temozolomide—melanoma	0.00211	0.00319	CcSEcCtD
Brinzolamide—Chest pain—Bleomycin—melanoma	0.00209	0.00317	CcSEcCtD
Brinzolamide—Myalgia—Bleomycin—melanoma	0.00209	0.00317	CcSEcCtD
Brinzolamide—Abdominal pain upper—Docetaxel—melanoma	0.00209	0.00317	CcSEcCtD
Brinzolamide—Rash—Vemurafenib—melanoma	0.00209	0.00316	CcSEcCtD
Brinzolamide—Mental disorder—Temozolomide—melanoma	0.00209	0.00316	CcSEcCtD
Brinzolamide—Dermatitis—Vemurafenib—melanoma	0.00209	0.00316	CcSEcCtD
Brinzolamide—Back pain—Carmustine—melanoma	0.00208	0.00314	CcSEcCtD
Brinzolamide—Headache—Vemurafenib—melanoma	0.00208	0.00314	CcSEcCtD
Brinzolamide—Erythema—Temozolomide—melanoma	0.00207	0.00314	CcSEcCtD
Brinzolamide—Malnutrition—Temozolomide—melanoma	0.00207	0.00314	CcSEcCtD
Brinzolamide—Breast disorder—Docetaxel—melanoma	0.00207	0.00313	CcSEcCtD
Brinzolamide—Discomfort—Bleomycin—melanoma	0.00207	0.00313	CcSEcCtD
Brinzolamide—Malaise—Dactinomycin—melanoma	0.00207	0.00313	CcSEcCtD
Brinzolamide—Nasopharyngitis—Docetaxel—melanoma	0.00205	0.0031	CcSEcCtD
Brinzolamide—CA2—mammalian vulva—melanoma	0.00204	0.0207	CbGeAlD
Brinzolamide—Dysgeusia—Temozolomide—melanoma	0.00203	0.00307	CcSEcCtD
Brinzolamide—Vision blurred—Carmustine—melanoma	0.00202	0.00306	CcSEcCtD
Brinzolamide—Tremor—Carmustine—melanoma	0.00201	0.00304	CcSEcCtD
Brinzolamide—Back pain—Temozolomide—melanoma	0.00201	0.00304	CcSEcCtD
Brinzolamide—Infection—Bleomycin—melanoma	0.00199	0.00302	CcSEcCtD
Brinzolamide—Agitation—Carmustine—melanoma	0.00197	0.00299	CcSEcCtD
Brinzolamide—Nausea—Vemurafenib—melanoma	0.00197	0.00298	CcSEcCtD
Brinzolamide—Vision blurred—Temozolomide—melanoma	0.00196	0.00296	CcSEcCtD
Brinzolamide—Myalgia—Dactinomycin—melanoma	0.00195	0.00296	CcSEcCtD
Brinzolamide—Tremor—Temozolomide—melanoma	0.00194	0.00294	CcSEcCtD
Brinzolamide—Discomfort—Dactinomycin—melanoma	0.00193	0.00292	CcSEcCtD
Brinzolamide—Angina pectoris—Docetaxel—melanoma	0.00193	0.00292	CcSEcCtD
Brinzolamide—Ill-defined disorder—Temozolomide—melanoma	0.00192	0.00291	CcSEcCtD
Brinzolamide—Agitation—Temozolomide—melanoma	0.00191	0.00289	CcSEcCtD
Brinzolamide—Hypotension—Bleomycin—melanoma	0.00188	0.00284	CcSEcCtD
Brinzolamide—Malaise—Temozolomide—melanoma	0.00187	0.00283	CcSEcCtD
Brinzolamide—Vertigo—Temozolomide—melanoma	0.00186	0.00282	CcSEcCtD
Brinzolamide—Infection—Dactinomycin—melanoma	0.00186	0.00281	CcSEcCtD
Brinzolamide—Hypertension—Carmustine—melanoma	0.00185	0.0028	CcSEcCtD
Brinzolamide—Palpitations—Temozolomide—melanoma	0.00183	0.00277	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00183	0.00277	CcSEcCtD
Brinzolamide—Chest pain—Carmustine—melanoma	0.00183	0.00277	CcSEcCtD
Brinzolamide—Myalgia—Carmustine—melanoma	0.00183	0.00277	CcSEcCtD
Brinzolamide—Cough—Temozolomide—melanoma	0.00181	0.00274	CcSEcCtD
Brinzolamide—Paraesthesia—Bleomycin—melanoma	0.0018	0.00273	CcSEcCtD
Brinzolamide—Hypertension—Temozolomide—melanoma	0.00179	0.00271	CcSEcCtD
Brinzolamide—Dyspnoea—Bleomycin—melanoma	0.00179	0.00271	CcSEcCtD
Brinzolamide—CA5B—lymph node—melanoma	0.00179	0.0181	CbGeAlD
Brinzolamide—Arthralgia—Temozolomide—melanoma	0.00177	0.00267	CcSEcCtD
Brinzolamide—Myalgia—Temozolomide—melanoma	0.00177	0.00267	CcSEcCtD
Brinzolamide—Infestation NOS—Docetaxel—melanoma	0.00177	0.00267	CcSEcCtD
Brinzolamide—Infestation—Docetaxel—melanoma	0.00177	0.00267	CcSEcCtD
Brinzolamide—CA4—head—melanoma	0.00176	0.0178	CbGeAlD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00175	0.00265	CcSEcCtD
Brinzolamide—Discomfort—Temozolomide—melanoma	0.00175	0.00264	CcSEcCtD
Brinzolamide—Decreased appetite—Bleomycin—melanoma	0.00174	0.00264	CcSEcCtD
Brinzolamide—Infection—Carmustine—melanoma	0.00174	0.00263	CcSEcCtD
Brinzolamide—Dry mouth—Temozolomide—melanoma	0.00173	0.00261	CcSEcCtD
Brinzolamide—Pain—Bleomycin—melanoma	0.00172	0.0026	CcSEcCtD
Brinzolamide—Conjunctivitis—Docetaxel—melanoma	0.00172	0.0026	CcSEcCtD
Brinzolamide—Tachycardia—Carmustine—melanoma	0.00171	0.00259	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00171	0.00258	CcSEcCtD
Brinzolamide—Infection—Temozolomide—melanoma	0.00168	0.00255	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Docetaxel—melanoma	0.00167	0.00253	CcSEcCtD
Brinzolamide—Epistaxis—Docetaxel—melanoma	0.00167	0.00252	CcSEcCtD
Brinzolamide—Nervous system disorder—Temozolomide—melanoma	0.00166	0.00251	CcSEcCtD
Brinzolamide—Feeling abnormal—Bleomycin—melanoma	0.00165	0.0025	CcSEcCtD
Brinzolamide—Skin disorder—Temozolomide—melanoma	0.00164	0.00249	CcSEcCtD
Brinzolamide—Hypotension—Carmustine—melanoma	0.00164	0.00248	CcSEcCtD
Brinzolamide—Decreased appetite—Dactinomycin—melanoma	0.00163	0.00246	CcSEcCtD
Brinzolamide—Fatigue—Dactinomycin—melanoma	0.00161	0.00244	CcSEcCtD
Brinzolamide—Pain—Dactinomycin—melanoma	0.0016	0.00242	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Carmustine—melanoma	0.0016	0.00242	CcSEcCtD
Brinzolamide—Urticaria—Bleomycin—melanoma	0.00159	0.00241	CcSEcCtD
Brinzolamide—Rhinitis—Docetaxel—melanoma	0.00159	0.0024	CcSEcCtD
Brinzolamide—Insomnia—Carmustine—melanoma	0.00158	0.0024	CcSEcCtD
Brinzolamide—CA1—lymph node—melanoma	0.00158	0.016	CbGeAlD
Brinzolamide—Hypoaesthesia—Docetaxel—melanoma	0.00158	0.00239	CcSEcCtD
Brinzolamide—Paraesthesia—Carmustine—melanoma	0.00157	0.00238	CcSEcCtD
Brinzolamide—Pharyngitis—Docetaxel—melanoma	0.00157	0.00238	CcSEcCtD
Brinzolamide—Urinary tract disorder—Docetaxel—melanoma	0.00157	0.00237	CcSEcCtD
Brinzolamide—Dyspnoea—Carmustine—melanoma	0.00156	0.00236	CcSEcCtD
Brinzolamide—Oedema peripheral—Docetaxel—melanoma	0.00156	0.00236	CcSEcCtD
Brinzolamide—Somnolence—Carmustine—melanoma	0.00156	0.00236	CcSEcCtD
Brinzolamide—Connective tissue disorder—Docetaxel—melanoma	0.00156	0.00236	CcSEcCtD
Brinzolamide—Urethral disorder—Docetaxel—melanoma	0.00155	0.00235	CcSEcCtD
Brinzolamide—Feeling abnormal—Dactinomycin—melanoma	0.00154	0.00233	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00154	0.00233	CcSEcCtD
Brinzolamide—Insomnia—Temozolomide—melanoma	0.00153	0.00232	CcSEcCtD
Brinzolamide—Visual impairment—Docetaxel—melanoma	0.00153	0.00231	CcSEcCtD
Brinzolamide—Decreased appetite—Carmustine—melanoma	0.00152	0.0023	CcSEcCtD
Brinzolamide—Paraesthesia—Temozolomide—melanoma	0.00152	0.0023	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Carmustine—melanoma	0.00151	0.00229	CcSEcCtD
Brinzolamide—Dyspnoea—Temozolomide—melanoma	0.00151	0.00228	CcSEcCtD
Brinzolamide—Somnolence—Temozolomide—melanoma	0.00151	0.00228	CcSEcCtD
Brinzolamide—Pain—Carmustine—melanoma	0.0015	0.00227	CcSEcCtD
Brinzolamide—Dyspepsia—Temozolomide—melanoma	0.00149	0.00226	CcSEcCtD
Brinzolamide—Eye disorder—Docetaxel—melanoma	0.00148	0.00224	CcSEcCtD
Brinzolamide—Hypersensitivity—Bleomycin—melanoma	0.00148	0.00224	CcSEcCtD
Brinzolamide—Decreased appetite—Temozolomide—melanoma	0.00147	0.00223	CcSEcCtD
Brinzolamide—Cardiac disorder—Docetaxel—melanoma	0.00147	0.00223	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00146	0.00221	CcSEcCtD
Brinzolamide—Fatigue—Temozolomide—melanoma	0.00146	0.00221	CcSEcCtD
Brinzolamide—CA2—head—melanoma	0.00146	0.0148	CbGeAlD
Brinzolamide—Pain—Temozolomide—melanoma	0.00145	0.00219	CcSEcCtD
Brinzolamide—Feeling abnormal—Carmustine—melanoma	0.00144	0.00218	CcSEcCtD
Brinzolamide—Asthenia—Bleomycin—melanoma	0.00144	0.00218	CcSEcCtD
Brinzolamide—Angiopathy—Docetaxel—melanoma	0.00144	0.00218	CcSEcCtD
Brinzolamide—Immune system disorder—Docetaxel—melanoma	0.00143	0.00217	CcSEcCtD
Brinzolamide—Mediastinal disorder—Docetaxel—melanoma	0.00143	0.00216	CcSEcCtD
Brinzolamide—Pruritus—Bleomycin—melanoma	0.00142	0.00215	CcSEcCtD
Brinzolamide—Arrhythmia—Docetaxel—melanoma	0.00142	0.00214	CcSEcCtD
Brinzolamide—Alopecia—Docetaxel—melanoma	0.0014	0.00212	CcSEcCtD
Brinzolamide—Feeling abnormal—Temozolomide—melanoma	0.0014	0.00211	CcSEcCtD
Brinzolamide—Mental disorder—Docetaxel—melanoma	0.00139	0.0021	CcSEcCtD
Brinzolamide—Erythema—Docetaxel—melanoma	0.00138	0.00209	CcSEcCtD
Brinzolamide—Malnutrition—Docetaxel—melanoma	0.00138	0.00209	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—melanoma	0.00138	0.00209	CcSEcCtD
Brinzolamide—Dysgeusia—Docetaxel—melanoma	0.00135	0.00204	CcSEcCtD
Brinzolamide—Urticaria—Temozolomide—melanoma	0.00135	0.00204	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—melanoma	0.00134	0.00203	CcSEcCtD
Brinzolamide—Back pain—Docetaxel—melanoma	0.00133	0.00202	CcSEcCtD
Brinzolamide—Muscle spasms—Docetaxel—melanoma	0.00133	0.00201	CcSEcCtD
Brinzolamide—Hypersensitivity—Carmustine—melanoma	0.00129	0.00195	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—melanoma	0.00128	0.00194	CcSEcCtD
Brinzolamide—Vomiting—Bleomycin—melanoma	0.00128	0.00193	CcSEcCtD
Brinzolamide—Rash—Bleomycin—melanoma	0.00127	0.00192	CcSEcCtD
Brinzolamide—Dermatitis—Bleomycin—melanoma	0.00126	0.00191	CcSEcCtD
Brinzolamide—Asthenia—Carmustine—melanoma	0.00126	0.0019	CcSEcCtD
Brinzolamide—Hypersensitivity—Temozolomide—melanoma	0.00125	0.00189	CcSEcCtD
Brinzolamide—CA4—lymph node—melanoma	0.00123	0.0125	CbGeAlD
Brinzolamide—Palpitations—Docetaxel—melanoma	0.00122	0.00185	CcSEcCtD
Brinzolamide—Asthenia—Temozolomide—melanoma	0.00121	0.00184	CcSEcCtD
Brinzolamide—Cough—Docetaxel—melanoma	0.0012	0.00182	CcSEcCtD
Brinzolamide—Diarrhoea—Carmustine—melanoma	0.0012	0.00181	CcSEcCtD
Brinzolamide—Pruritus—Temozolomide—melanoma	0.0012	0.00181	CcSEcCtD
Brinzolamide—Nausea—Bleomycin—melanoma	0.00119	0.0018	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—melanoma	0.00119	0.0018	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—melanoma	0.00119	0.0018	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—melanoma	0.00118	0.00179	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—melanoma	0.00117	0.00178	CcSEcCtD
Brinzolamide—Myalgia—Docetaxel—melanoma	0.00117	0.00178	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—melanoma	0.00117	0.00178	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00117	0.00177	CcSEcCtD
Brinzolamide—Dizziness—Carmustine—melanoma	0.00116	0.00175	CcSEcCtD
Brinzolamide—Diarrhoea—Temozolomide—melanoma	0.00116	0.00175	CcSEcCtD
Brinzolamide—Dry mouth—Docetaxel—melanoma	0.00115	0.00174	CcSEcCtD
Brinzolamide—Dizziness—Temozolomide—melanoma	0.00112	0.00169	CcSEcCtD
Brinzolamide—Infection—Docetaxel—melanoma	0.00112	0.00169	CcSEcCtD
Brinzolamide—Vomiting—Carmustine—melanoma	0.00111	0.00169	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—melanoma	0.00111	0.00168	CcSEcCtD
Brinzolamide—Rash—Carmustine—melanoma	0.0011	0.00167	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—melanoma	0.0011	0.00167	CcSEcCtD
Brinzolamide—Dermatitis—Carmustine—melanoma	0.0011	0.00167	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—melanoma	0.0011	0.00166	CcSEcCtD
Brinzolamide—Headache—Carmustine—melanoma	0.0011	0.00166	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—melanoma	0.00109	0.00166	CcSEcCtD
Brinzolamide—Vomiting—Temozolomide—melanoma	0.00108	0.00163	CcSEcCtD
Brinzolamide—Rash—Temozolomide—melanoma	0.00107	0.00162	CcSEcCtD
Brinzolamide—Dermatitis—Temozolomide—melanoma	0.00107	0.00161	CcSEcCtD
Brinzolamide—Headache—Temozolomide—melanoma	0.00106	0.00161	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—melanoma	0.00105	0.00159	CcSEcCtD
Brinzolamide—Nausea—Carmustine—melanoma	0.00104	0.00157	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.00103	0.00155	CcSEcCtD
Brinzolamide—CA2—lymph node—melanoma	0.00102	0.0103	CbGeAlD
Brinzolamide—Insomnia—Docetaxel—melanoma	0.00102	0.00154	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—melanoma	0.00101	0.00153	CcSEcCtD
Brinzolamide—Nausea—Temozolomide—melanoma	0.00101	0.00152	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—melanoma	0.001	0.00152	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—melanoma	0.001	0.00151	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—melanoma	0.000991	0.0015	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—melanoma	0.000979	0.00148	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000972	0.00147	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—melanoma	0.000971	0.00147	CcSEcCtD
Brinzolamide—Pain—Docetaxel—melanoma	0.000963	0.00146	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—melanoma	0.000928	0.0014	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—melanoma	0.00083	0.00126	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—melanoma	0.000808	0.00122	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—melanoma	0.000797	0.00121	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—melanoma	0.00077	0.00117	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—melanoma	0.000745	0.00113	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—melanoma	0.000716	0.00108	CcSEcCtD
Brinzolamide—Rash—Docetaxel—melanoma	0.00071	0.00107	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—melanoma	0.000709	0.00107	CcSEcCtD
Brinzolamide—Headache—Docetaxel—melanoma	0.000705	0.00107	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—melanoma	0.000669	0.00101	CcSEcCtD
Brinzolamide—CA9—Cellular responses to stress—CDKN2A—melanoma	0.000243	0.00117	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP17A1—melanoma	0.000242	0.00117	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP17A1—melanoma	0.000242	0.00117	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC5A5—melanoma	0.000241	0.00116	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CUBN—melanoma	0.000239	0.00115	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—FASN—melanoma	0.000239	0.00115	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—FASN—melanoma	0.000239	0.00115	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MDM2—melanoma	0.000236	0.00114	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PLA2G6—melanoma	0.000236	0.00114	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC5A5—melanoma	0.000235	0.00113	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC5A5—melanoma	0.000235	0.00113	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GNAQ—melanoma	0.000233	0.00112	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CD44—melanoma	0.000233	0.00112	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SDHD—melanoma	0.000231	0.00111	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—BSG—melanoma	0.000231	0.00111	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CSPG4—melanoma	0.000231	0.00111	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GNA11—melanoma	0.000228	0.0011	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GNA11—melanoma	0.000228	0.0011	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GNAQ—melanoma	0.000227	0.0011	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GNAQ—melanoma	0.000227	0.0011	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CD44—melanoma	0.000227	0.0011	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CD44—melanoma	0.000227	0.0011	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PLA2G6—melanoma	0.000226	0.00109	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000225	0.00109	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPAM—melanoma	0.000224	0.00108	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP17A1—melanoma	0.000224	0.00108	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1B1—melanoma	0.000224	0.00108	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—FASN—melanoma	0.000223	0.00108	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—FASN—melanoma	0.000223	0.00108	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CXCL8—melanoma	0.00022	0.00106	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC5A5—melanoma	0.00022	0.00106	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC5A5—melanoma	0.00022	0.00106	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1B1—melanoma	0.000218	0.00105	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1B1—melanoma	0.000218	0.00105	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PLA2G6—melanoma	0.000217	0.00104	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1B—melanoma	0.000215	0.00104	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GNAQ—melanoma	0.000212	0.00102	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GNAQ—melanoma	0.000212	0.00102	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CD44—melanoma	0.000212	0.00102	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CD44—melanoma	0.000212	0.00102	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—VCAN—melanoma	0.000212	0.00102	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GNA11—melanoma	0.000211	0.00102	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—FASN—melanoma	0.000207	0.000998	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SLC5A5—melanoma	0.000204	0.000982	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1B1—melanoma	0.000203	0.000981	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1B1—melanoma	0.000203	0.000981	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—VCAN—melanoma	0.000203	0.000978	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1A—melanoma	0.000199	0.000958	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—NFKB1—melanoma	0.000197	0.000951	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GNAQ—melanoma	0.000197	0.000948	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CD44—melanoma	0.000197	0.000948	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—VCAN—melanoma	0.000194	0.000938	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PLA2G6—melanoma	0.00019	0.000918	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1B1—melanoma	0.000188	0.000909	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ABCB1—melanoma	0.000184	0.000888	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ABCB1—melanoma	0.000179	0.000865	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ABCB1—melanoma	0.000179	0.000865	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—melanoma	0.000179	0.000863	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP17A1—melanoma	0.000179	0.000861	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—STAT3—melanoma	0.000177	0.000854	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP17A1—melanoma	0.000171	0.000826	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—VCAN—melanoma	0.000171	0.000825	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PRKCA—melanoma	0.000169	0.000817	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK3—melanoma	0.000169	0.000816	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GNA11—melanoma	0.000169	0.000813	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ERCC2—melanoma	0.000168	0.00081	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ABCB1—melanoma	0.000168	0.000808	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ABCB1—melanoma	0.000168	0.000808	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PRKCA—melanoma	0.000165	0.000796	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PRKCA—melanoma	0.000165	0.000796	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—FASN—melanoma	0.000165	0.000796	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP17A1—melanoma	0.000164	0.000791	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ERCC2—melanoma	0.000164	0.00079	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ERCC2—melanoma	0.000164	0.00079	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC5A5—melanoma	0.000162	0.000783	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GNA11—melanoma	0.000162	0.00078	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MAPK1—melanoma	0.000161	0.000777	CbGpPWpGaD
Brinzolamide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000161	0.000774	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—FASN—melanoma	0.000158	0.000763	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CD44—melanoma	0.000157	0.000756	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GNAQ—melanoma	0.000157	0.000756	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC5A5—melanoma	0.000156	0.00075	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ABCB1—melanoma	0.000155	0.000748	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GNA11—melanoma	0.000155	0.000747	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PRKCA—melanoma	0.000154	0.000743	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PRKCA—melanoma	0.000154	0.000743	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ERCC2—melanoma	0.000153	0.000737	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ERCC2—melanoma	0.000153	0.000737	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—FASN—melanoma	0.000152	0.000731	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GNAQ—melanoma	0.00015	0.000725	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1B1—melanoma	0.00015	0.000725	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CD44—melanoma	0.00015	0.000725	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC5A5—melanoma	0.000149	0.000719	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP17A1—melanoma	0.000144	0.000696	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GNAQ—melanoma	0.000144	0.000695	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CD44—melanoma	0.000144	0.000695	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1B1—melanoma	0.000144	0.000695	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PRKCA—melanoma	0.000143	0.000689	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000142	0.000685	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ERCC2—melanoma	0.000142	0.000683	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.00014	0.000675	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1B1—melanoma	0.000138	0.000666	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GNA11—melanoma	0.000136	0.000657	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—melanoma	0.000135	0.000652	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—FASN—melanoma	0.000133	0.000643	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—melanoma	0.000133	0.00064	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC5A5—melanoma	0.000131	0.000632	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—melanoma	0.000129	0.000624	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—melanoma	0.000129	0.000624	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—melanoma	0.000128	0.000618	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GNAQ—melanoma	0.000127	0.000611	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CD44—melanoma	0.000127	0.000611	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—melanoma	0.000125	0.000602	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—melanoma	0.000125	0.000602	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—melanoma	0.000124	0.000597	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—melanoma	0.000124	0.000597	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1B1—melanoma	0.000121	0.000586	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—melanoma	0.000121	0.000582	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—melanoma	0.000121	0.000582	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.00012	0.000576	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—melanoma	0.000119	0.000572	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000118	0.000569	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—melanoma	0.000117	0.000563	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—melanoma	0.000117	0.000562	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—melanoma	0.000117	0.000562	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—melanoma	0.000115	0.000555	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PRKCA—melanoma	0.000114	0.000549	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—melanoma	0.000114	0.000549	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—melanoma	0.000114	0.000548	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—melanoma	0.000114	0.000548	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ERCC2—melanoma	0.000113	0.000545	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—melanoma	0.000112	0.000541	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—melanoma	0.000112	0.000541	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—melanoma	0.000112	0.000539	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PRKCA—melanoma	0.000109	0.000527	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ERCC2—melanoma	0.000108	0.000522	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—melanoma	0.000108	0.000521	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—melanoma	0.000106	0.000512	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—melanoma	0.000106	0.000512	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—melanoma	0.000105	0.000505	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—melanoma	0.000105	0.000505	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PRKCA—melanoma	0.000105	0.000505	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ERCC2—melanoma	0.000104	0.000501	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—melanoma	0.000102	0.00049	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—melanoma	0.000101	0.000486	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—melanoma	0.0001	0.000482	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—melanoma	9.91e-05	0.000478	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—melanoma	9.91e-05	0.000478	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—melanoma	9.83e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—melanoma	9.82e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—melanoma	9.82e-05	0.000474	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—melanoma	9.71e-05	0.000468	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—melanoma	9.25e-05	0.000446	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—melanoma	9.25e-05	0.000446	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PRKCA—melanoma	9.2e-05	0.000444	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—melanoma	9.17e-05	0.000442	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—melanoma	9.17e-05	0.000442	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ERCC2—melanoma	9.13e-05	0.00044	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—melanoma	8.92e-05	0.00043	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—melanoma	8.79e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—melanoma	8.61e-05	0.000415	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—melanoma	8.57e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—melanoma	8.56e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—melanoma	8.56e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—melanoma	8.55e-05	0.000412	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—melanoma	8.49e-05	0.00041	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—melanoma	8.25e-05	0.000398	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—melanoma	8.2e-05	0.000395	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—melanoma	7.99e-05	0.000386	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—melanoma	7.99e-05	0.000386	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACER3—melanoma	7.97e-05	0.000384	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—melanoma	7.91e-05	0.000382	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—melanoma	7.84e-05	0.000378	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—melanoma	7.74e-05	0.000373	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—melanoma	7.52e-05	0.000363	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—melanoma	7.42e-05	0.000358	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—melanoma	7.41e-05	0.000357	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT2B10—melanoma	7.29e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—melanoma	7.21e-05	0.000348	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—melanoma	7.21e-05	0.000348	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—melanoma	7.12e-05	0.000343	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—melanoma	6.96e-05	0.000336	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—melanoma	6.84e-05	0.00033	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HS3ST5—melanoma	6.78e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—melanoma	6.77e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—melanoma	6.55e-05	0.000316	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—melanoma	6.49e-05	0.000313	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—melanoma	6.34e-05	0.000306	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—melanoma	6.28e-05	0.000303	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—melanoma	6.26e-05	0.000302	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—melanoma	6.23e-05	0.0003	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—melanoma	6.2e-05	0.000299	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—melanoma	6.04e-05	0.000291	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—melanoma	6.04e-05	0.000291	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—melanoma	5.91e-05	0.000285	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—melanoma	5.66e-05	0.000273	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—melanoma	5.64e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—melanoma	5.64e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—melanoma	5.52e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—melanoma	5.47e-05	0.000264	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—melanoma	5.43e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—melanoma	5.23e-05	0.000252	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLCB4—melanoma	5.13e-05	0.000248	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—melanoma	5.06e-05	0.000244	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—melanoma	4.94e-05	0.000238	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—melanoma	4.94e-05	0.000238	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC6A11—melanoma	4.83e-05	0.000233	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIP4K2A—melanoma	4.83e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—melanoma	4.77e-05	0.00023	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTAP—melanoma	4.7e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—melanoma	4.61e-05	0.000222	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—melanoma	4.61e-05	0.000222	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—melanoma	4.27e-05	0.000206	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PHGDH—melanoma	4.19e-05	0.000202	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LUM—melanoma	4.19e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—melanoma	4.17e-05	0.000201	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPSE—melanoma	4.1e-05	0.000198	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CUBN—melanoma	4.03e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—melanoma	3.99e-05	0.000193	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SDHD—melanoma	3.89e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CSPG4—melanoma	3.89e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BSG—melanoma	3.89e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—melanoma	3.83e-05	0.000185	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPAM—melanoma	3.77e-05	0.000182	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—melanoma	3.4e-05	0.000164	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—melanoma	3.37e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—melanoma	3.26e-05	0.000157	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLA2G6—melanoma	3.2e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—melanoma	3.13e-05	0.000151	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—VCAN—melanoma	2.88e-05	0.000139	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—melanoma	2.75e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP17A1—melanoma	2.43e-05	0.000117	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNA11—melanoma	2.29e-05	0.000111	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FASN—melanoma	2.24e-05	0.000108	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A5—melanoma	2.21e-05	0.000106	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNAQ—melanoma	2.13e-05	0.000103	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CD44—melanoma	2.13e-05	0.000103	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1B1—melanoma	2.04e-05	9.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—melanoma	1.68e-05	8.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PRKCA—melanoma	1.55e-05	7.47e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ERCC2—melanoma	1.54e-05	7.41e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—melanoma	1.21e-05	5.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—melanoma	1.17e-05	5.65e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—melanoma	1.07e-05	5.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—melanoma	1.05e-05	5.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—melanoma	9.3e-06	4.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—melanoma	9.21e-06	4.44e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—melanoma	8.03e-06	3.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—melanoma	5.67e-06	2.73e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—melanoma	4.63e-06	2.23e-05	CbGpPWpGaD
